ArticleTranslational lung cancer research2020

Rechallenge with erlotinib in osimertinib-resistant lung adenocarcinoma mediated by driver gene loss: a case report.

Lingli Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.